QUAY STEVEN C

CIK 00010082272 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001008227

Recent Transactions

50 trades

Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Options (right to buy)
2026-01-20$0.60/sh+950,000→ 950,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2026-01-20+325,203→ 339,101 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2025-05-21$0.88/sh+11,239→ 13,898 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2025-05-15+1,366,062→ 1,366,062 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2024-06-27+1,795,100→ 1,795,100 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2023-03-02+1,873,100→ 1,873,100 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2022-02-24+1,900,000→ 1,900,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-05-14+1,900,000→ 1,900,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-05-14+1,900,000→ 1,900,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (Right to Buy)
2020-04-09+1,305,000→ 1,305,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (Right to Buy)
2020-04-09+195,000→ 195,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (Right to Buy)
2019-01-13+2,300,000→ 2,300,000 total
Disposition to Issuer
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (Right to Buy)
2019-01-13−2,300,000→ 0 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2018-06-27+2,300,000→ 2,300,000 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Series B Convertible Preferred Stock
2018-05-30$1000.00/sh+8→ 8 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Warrants
2018-05-30$1000.00/sh+2,272→ 2,272 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2017-05-24+575,893→ 651,785 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock (right to buy)
2016-05-18+569,194→ 569,194 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2016-03-09$0.37/sh+15,000→ 4,826,858 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2016-02-16$0.53/sh+15,000→ 4,811,858 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2016-01-19$0.20/sh+50,000→ 4,796,858 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Options
2015-03-16+275,000→ 275,000 total
Sale
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2013-10-01$5.66/sh−7,265→ 4,268,315 total
Gift
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2013-07-18−5,000→ 478,543 total
Gift
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2013-07-18−100,000→ 483,543 total
Gift
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2013-05-28−1,000→ 583,543 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2013-03-11+44,194→ 44,194 total
Award
Adhera Therapeutics, Inc.$ATRX
Common Stock of MDRNA, Inc.
2009-03-20+731,275→ 1,166,504 total
Other
Adhera Therapeutics, Inc.$ATRX
Common Stock Options of MDRNA, Inc.
2009-03-16$12.94/sh−800,000→ 1,704,247 total
Other
Adhera Therapeutics, Inc.$ATRX
Common Stock Options of MDRNA, Inc.
2008-10-28$25.00/sh−100,000→ 2,504,247 total
Other
Adhera Therapeutics, Inc.$ATRX
Common Stock Options of MDRNA, Inc.
2008-10-28$14.72/sh−600,000→ 2,604,247 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2007-06-07$11.31/sh−2,000→ 457,462 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2007-06-07$10.95/sh−400→ 453,062 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-06-15$14.73/sh−1,540→ 502,410 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-06-15$14.34/sh−2,000→ 505,950 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-03-16$15.87/sh−400→ 517,600 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-03-16$16.25/sh−1,550→ 516,050 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-03-16$16.30/sh−2,000→ 513,050 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-03-16$16.26/sh−1,000→ 515,050 total
Disposition to Issuer
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Stock Options
2006-02-01$9.78/sh−1,333→ 2,667 total
Disposition to Issuer
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2006-02-01−852→ 165 total
Award
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Stock Options
2005-07-20$14.72/sh+600,000→ 1,545,846 total
Award
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Company Inc Common Stock
2005-07-20+168,000→ 436,000 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.17/sh−3,500→ 268,000 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.03/sh−492→ 308,818 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.01/sh−100→ 309,310 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.14/sh−3,854→ 304,964 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.16/sh−15,315→ 271,500 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.00/sh−12,744→ 309,410 total
Sale
Adhera Therapeutics, Inc.$ATRX
Nastech Pharmaceutical Co. Common Stock
2005-07-11$15.15/sh−18,149→ 286,815 total

Companies

Recent Filings

Address

C/O ATOSSA THERAPEUTICS, INC., 1448 NW MARKET STREET, SUITE 500

SEATTLE, WA, 98107

View on SEC.gov